The U.S. Food and Drug Administration (FDA) is reportedly rolling out a new cash‑bonus program to reward drug reviewers who deliver high‑quality decisions ahead of schedule, a move pitched as both a modernization of government HR and a lifeline for an agency…
Oracle’s (ORCL) latest round of layoffs is less a retreat than a high‑stakes reshuffling for the age of artificial intelligence, as the software giant trades payroll for power plants in a bid to secure its place in the cloud big leagues.
A…
Broadcom’s (AVGO) chief executive is sounding less like a cautious chipmaker and more like the maître d’ of a very exclusive AI banquet, calmly assuring investors that the kitchen can handle the rush. In this rapidly evolving feast, Nvidia (NVDA) is serving…
Insulin pumps are having a moment, and this time it is not just Wall Street that is impressed—it is patients, payers, and, increasingly, competitors playing catch‑up.
Insulet’s Growth Streak Enters Double Digits
Insulet (PODD) closed 2025 like a company that never got…
US stocks rebounded on Wednesday, March 4, 2026, as easing fears around the Iran conflict and steadier oil prices helped buyers step back in, while Bitcoin extended its latest surge.
Index performance
The major US benchmarks climbed, recapturing a chunk of the…
Intel (INTC) is trying very hard to make “old-school silicon” sound like the hottest asset class in town—and, judging from its latest press run, the company may be getting somewhere.
A Boardroom Tune-Up for the AI PC Era
Intel’s most recent headline…
Actelis Networks (NASDAQ: ASNS) is hardly a household name, but in California’s latest highway overhaul, the quiet specialist in hybrid fiber-copper networking just got the green light in a big way. The company has landed an order from the California Department of Transportation (Caltrans)…
DoubleVerify (NYSE: DV) has spent the opening months of 2026 behaving less like an ad-tech vendor and more like a company intent on rewriting the operating manual for digital media trust.
Streaming TV Grows Up: DV’s CES Moment
At CES 2026, DoubleVerify…
In the end, it was not a jury but a checkbook that settled one of biotech’s more closely watched intellectual-property dramas. Moderna will pay up to 2.25 billion dollars to Genevant Sciences and Arbutus Biopharma to resolve a global web of patent…
Nokia's (NOK) Network as Code platform is gaining global momentum, drawing major telecom giants into a collaborative ecosystem that promises to revolutionize programmable connectivity. With fresh partnerships and AI integrations, the Finnish telecom leader is scripting a narrative of innovation that's as…
